Fig. 2From: Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancerRisk of recurrence according to CA-125 changes 3 (a) and 6 (b) months after the treatment. Both splins showed statistically significant linear and non-linear increase in recurrence risk 3 and 6 months after the treatmentBack to article page